BSE Live
Jan 27, 16:01Prev. Close
207.35
Open Price
205.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 27, 15:55Prev. Close
207.16
Open Price
210.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
203.85 (1044)
| Balance Sheet of Viyash Scientific (in Rs. Cr.) | Mar 05 | Mar 04 | |
| 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | |||
| SHAREHOLDER'S FUNDS | |||
| Equity Share Capital | 6.50 | 6.50 | |
| Total Share Capital | 11.95 | 11.95 | |
| Reserves and Surplus | 9.56 | 6.49 | |
| Total Reserves and Surplus | 9.56 | 6.49 | |
| Total Shareholders Funds | 21.51 | 18.44 | |
| NON-CURRENT LIABILITIES | |||
| Long Term Borrowings | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 1.10 | 0.83 | |
| Other Long Term Liabilities | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 1.10 | 0.83 | |
| CURRENT LIABILITIES | |||
| Short Term Borrowings | 0.00 | 0.70 | |
| Trade Payables | 2.24 | 2.97 | |
| Other Current Liabilities | 0.00 | 0.00 | |
| Short Term Provisions | 2.27 | 0.86 | |
| Total Current Liabilities | 4.51 | 4.52 | |
| Total Capital And Liabilities | 27.13 | 23.79 | |
| ASSETS | |||
| NON-CURRENT ASSETS | |||
| Tangible Assets | 10.58 | 9.38 | |
| Intangible Assets | 0.00 | 0.00 | |
| Capital Work-In-Progress | 0.24 | 0.11 | |
| Other Assets | 0.00 | 0.00 | |
| Fixed Assets | 10.82 | 9.49 | |
| Non-Current Investments | 0.09 | 0.09 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | |
| Total Non-Current Assets | 10.91 | 9.58 | |
| CURRENT ASSETS | |||
| Current Investments | 0.00 | 0.00 | |
| Inventories | 1.70 | 1.68 | |
| Trade Receivables | 5.56 | 4.53 | |
| Cash And Cash Equivalents | 2.85 | 1.01 | |
| Short Term Loans And Advances | 6.01 | 6.89 | |
| OtherCurrentAssets | 0.09 | 0.09 | |
| Total Current Assets | 16.22 | 14.21 | |
| Total Assets | 27.13 | 23.79 | |
| OTHER ADDITIONAL INFORMATION | |||
| CONTINGENT LIABILITIES, COMMITMENTS | |||
| Contingent Liabilities | 0.25 | 0.20 | |
| CIF VALUE OF IMPORTS | |||
| Raw Materials | 1.01 | 0.24 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | |||
| Expenditure In Foreign Currency | 0.13 | 0.06 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | |||
| Dividend Remittance In Foreign Currency | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | |||
| FOB Value Of Goods | 7.54 | 2.52 | |
| Other Earnings | 0.26 | 0.22 | |
| BONUS DETAILS | |||
| Bonus Equity Share Capital | -- | -- | |
| NON-CURRENT INVESTMENTS | |||
| Non-Current Investments Quoted Market Value | -- | -- | |
| Non-Current Investments Unquoted Book Value | 0.06 | 0.06 | |
| CURRENT INVESTMENTS | |||
| Current Investments Quoted Market Value | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- |
02.12.2025
Sequent Scienti Standalone September 2025 Net Sales at Rs 34.03 crore, down 18.96% Y-o-Y
22.08.2025
Sequent Scienti Standalone June 2025 Net Sales at Rs 41.07 crore, down 28.78% Y-o-Y
21.05.2025
Sequent Scienti Standalone March 2025 Net Sales at Rs 42.33 crore, up 15.12% Y-o-Y
24.02.2025
Sequent Scienti Consolidated December 2024 Net Sales at Rs 390.81 crore, up 18.66% Y-o-Y